Correlation Between Champions Oncology and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Atea Pharmaceuticals, you can compare the effects of market volatilities on Champions Oncology and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Atea Pharmaceuticals.
Diversification Opportunities for Champions Oncology and Atea Pharmaceuticals
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Champions and Atea is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Champions Oncology i.e., Champions Oncology and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Champions Oncology and Atea Pharmaceuticals
Given the investment horizon of 90 days Champions Oncology is expected to generate 1.42 times more return on investment than Atea Pharmaceuticals. However, Champions Oncology is 1.42 times more volatile than Atea Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 398.00 in Champions Oncology on August 29, 2024 and sell it today you would earn a total of 35.00 from holding Champions Oncology or generate 8.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Champions Oncology |
| Atea Pharmaceuticals |
Champions Oncology and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Atea Pharmaceuticals
The main advantage of trading using opposite Champions Oncology and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Champions Oncology vs. Bright Minds Biosciences | Champions Oncology vs. HP Inc | Champions Oncology vs. Intel | Champions Oncology vs. Chevron Corp |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |